The Indian Pharma Blog

Launched by Novo Nordisk, Semaglutide is the world’s first and only GLP-1 RA (GLP-1 receptor analogue). The oral Semaglutide in India is registered by DCGI. According to Semaglutide manufacturer, it is used to treat Type 2 Diabetes (T2D). This medication is developed in the form of oral...

Lasinone contains active ingredient Nitisinone. This oral medication is commercially available in 10 mg, 5 mg, and 2 mg capsules for oral administration. According to Lasinone manufacturer, This medicine works in order to prevent the body from crumbling an amino acid known as tyrosine and by...

On July 20th, 2018, the US Food and Drug Administration approved Tibsovo (ivosidenib manufactured by Agios Pharma), an oral targeted treatment that blocks IDH1, for the treatment of adult individuals with relapsed/refractory (RR) acute myeloid leukemia (AML) and susceptible mutation named IDH1....